Efficacy of dulaglutide on vascular health indexes in subjects with type 2 diabetes: a randomized trial

BACKGROUND: Recent cardiovascular outcome trials have shown significant reductions in major cardiovascular (CV) events with glucagon-like peptide (GLP)-1 receptor agonists. Additionally, adjunctive surrogates for cardiovascular risk validated by some studies include arterial stiffness and endothelia...

Descripción completa

Detalles Bibliográficos
Autores principales: Tuttolomondo, Antonino, Cirrincione, Anna, Casuccio, Alessandra, Del Cuore, Alessandro, Daidone, Mario, Di Chiara, Tiziana, Di Raimondo, Domenico, Corte, Vittoriano Della, Maida, Carlo, Simonetta, Irene, Scaglione, Stefania, Pinto, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784355/
https://www.ncbi.nlm.nih.gov/pubmed/33397395
http://dx.doi.org/10.1186/s12933-020-01183-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784355/
https://www.ncbi.nlm.nih.gov/pubmed/33397395
http://dx.doi.org/10.1186/s12933-020-01183-5

Ejemplares similares